BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19110984)

  • 1. [Financial conflict of interest in clinical psychiatry studies: a review].
    Ulaş H; Binbay T; Alptekin K
    Turk Psikiyatri Derg; 2008; 19(4):418-26. PubMed ID: 19110984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry funding and author-industry affiliation in clinical trials in psychiatry.
    Montgomery JH
    Am J Psychiatry; 2006 Jun; 163(6):1110-1; author reply 1111. PubMed ID: 16741218
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relationship of psychiatrists to the pharmaceutical companies--part of, or the solution to, the problem].
    Insel TR
    Lege Artis Med; 2010 Sep; 20(9):630-1. PubMed ID: 21469310
    [No Abstract]   [Full Text] [Related]  

  • 5. Sponsorship bias in clinical research.
    Lexchin J
    Int J Risk Saf Med; 2012; 24(4):233-42. PubMed ID: 23135338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry funded clinical trials: bias and quality.
    Del Parigi A
    Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increase in incidence of drug treatments, ethical principles and conflict of interest in cooperation with the pharmaceutical industry].
    Hebebrand J; Blanz B; Herpertz-Dahlmann B; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 May; 40(3):133-8. PubMed ID: 22774235
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bitter and gilded pills: psychiatry in the light (or shadow) of the pharmaceutical industry].
    Vandereycken W
    Tijdschr Psychiatr; 2006; 48(2):119-29. PubMed ID: 16958195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scope and impact of financial conflicts of interest in biomedical research: a systematic review.
    Bekelman JE; Li Y; Gross CP
    JAMA; 2003 Jan 22-29; 289(4):454-65. PubMed ID: 12533125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who pays the piper?
    Friedli L
    Ment Health Today; 2003 Nov; ():8-9. PubMed ID: 14689593
    [No Abstract]   [Full Text] [Related]  

  • 12. Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.
    Lexchin J
    Sci Eng Ethics; 2012 Jun; 18(2):247-61. PubMed ID: 21327723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
    Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
    Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Navigating the Murky Waters of Conflict of Interest: Searching for the Middle Path.
    Zonia SC
    J Empir Res Hum Res Ethics; 2016 Feb; 11(1):67-71. PubMed ID: 27106892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
    Frank R
    Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflicts of interest in government-funded studies.
    Pickar JH
    Climacteric; 2015 Jun; 18(3):339-42. PubMed ID: 25690623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conflicts of interest in psychiatry: strategies to cultivate literacy in daily practice.
    Shimazawa R; Ikeda M
    Psychiatry Clin Neurosci; 2014 Jul; 68(7):489-97. PubMed ID: 24802771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between drug company funding and outcomes of clinical psychiatric research.
    Kelly RE; Cohen LJ; Semple RJ; Bialer P; Lau A; Bodenheimer A; Neustadter E; Barenboim A; Galynker II
    Psychol Med; 2006 Nov; 36(11):1647-56. PubMed ID: 16893480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatry has dangerous alliance with drug companies.
    Mosher LR
    Behav Healthc Tomorrow; 1999 Jun; 8(3):6. PubMed ID: 11645352
    [No Abstract]   [Full Text] [Related]  

  • 20. Biased articles.
    Friedman JH
    Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.